Company intelligence / Profile preview

Kurma Biofund

Paris, France

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Kurma Partners is a healthcare-focused asset manager that invests in biotech and healthcare companies rather than developing therapeutics itself.

Industry: Investors

Partnerships

Eurazeo (cornerstone investor in Biofund IV)Bpifrance (cornerstone investor in Biofund IV)CSL (cornerstone investor in Biofund IV)Pasteur Institute (academic partner)SATT Paris-Saclay (academic partner)IRB Barcelona (academic partner)

Beyond the preview

Go deeper on Kurma Biofund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kurma Biofund.

Explore the full profile